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Objectives
Identify the current society and guideline 
recommendations for the prevention of 
venous thromboembolisms (VTE).
Identify the risk and benefits of 
thromboprophylaxis intensities higher than 
prophylactic-dose.
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Background
Increase of risk of VTE 
suggested in critically ill 
patients infected with 
COVID-19.
JAMA. 2020;324(24):2548-2549.
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What anticoagulation dose 
should be used for critically 
ill patients infected with 
COVID-19 to prevent a VTE?
Tony Nguyen Baptist Hospital of Miami
Recommendations Overview
American Society of Hematology
NIH. Covid19treatmentguidelines.nih.gov [Internet]. [Cited 2021 Apr 5]
Kreuziger LB, et al. Hematology.org [Internet]. [Cited 2021 Apr 5]
Spyropoulos AC, et al. J Thromb Haemost. 2020 Aug;18(8):1859–65.
National Institutes of health
International Society of Thrombosis and Haemostasis
STATEMENT
Unless contraindicated, routine prophylactic dose anticoagulation is 
suggested/recommended for all patients who are hospitalized with a COVID-19 
infection.
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Recommendations Overview - 2
American Society of Hematology
NIH. Covid19treatmentguidelines.nih.gov [Internet]. [Cited 2021 Apr 5]
Kreuziger LB, et al. Hematology.org [Internet]. [Cited 2021 Apr 5]
Spyropoulos AC, et al. J Thromb Haemost. 2020 Aug;18(8):1859–65.
National Institutes of health
International Society of Thrombosis and Haemostasis
STATEMENT
Critically ill patients infected with COVID-19 should receive routine prophylactic dose 
anticoagulation. Patients with high risk of VTE may be considered for intermediate 
intensity anticoagulation.
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Recommendations Overview - 3
American Society of Hematology
NIH. Covid19treatmentguidelines.nih.gov [Internet]. [Cited 2021 Apr 5]
Kreuziger LB, et al. Hematology.org [Internet]. [Cited 2021 Apr 5]
Spyropoulos AC, et al. J Thromb Haemost. 2020 Aug;18(8):1859–65.
National Institutes of health
International Society of Thrombosis and Haemostasis
STATEMENT
Patients infected with COVID-19 with a high risk of VTE should receive treatment dose 
anticoagulation to prevent a VTE.
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Takeaway
NIH. Covid19treatmentguidelines.nih.gov [Internet]. [Cited 2021 Apr 5]
Kreuziger LB, et al. Hematology.org [Internet]. [Cited 2021 Apr 5]
Spyropoulos AC, et al. J Thromb Haemost. 2020 Aug;18(8):1859–65.
Unless contraindication, patients infected with 
COVID-19 should receive routine VTE 
prophylaxis
Unless contraindi ed, hosp talized patients 
infected with COVID-19 should receive routine VTE 
prophylaxis
Treatment dosing at this time is not recommended 





Anticoagulation higher than prophylactic 
dosing is controversial.
Tony Nguyen Baptist Hospital of Miami
Purpose
Evaluate the effects on clinical 
outcomes and ordering patterns of 
implementing an interim guidance 
document for thromboprophylaxis 
dosing in critically ill patients infected 
with COVID-19.
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Methods
Tony Nguyen Baptist Hospital of Miami
Design
Retrospective pre- and post-treatment 
guidance implementation study
Interim anticoagulation guidance document approved 
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Population
Inclusion
Adults with a COVID-19 infection 
admitted to the intensive care unit 
receiving anticoagulation for the primary 
prevention of a venous thromboembolism
Tony Nguyen Baptist Hospital of Miami
Population
Exclusion
▪ Chronic anticoagulation prior to admission
› E.g., recent VTE, atrial fibrillation, valve 
replacement, etc.
▪ Admission for or new acute onset disease 
requiring treatment intensity anticoagulation
▪ Length of ICU stay < 72 hrs.
▪ Pregnancy
▪ Incarceration
ICU Intensive care unit
Tony Nguyen Baptist Hospital of Miami
Intervention
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Intervention
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Intervention
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Intervention
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Elevated dosing - Standard
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Elevated Prophylaxis – Obese
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Elevated Prophylaxis - LBW
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Clinical Outcomes
Incidence of VTEs in 
patients admitted to the 
ICU with COVID-19










▪ Intervention success is defined as no difference in 
VTEs in the post-implementation group compared 
to pre-implementation group. 
▪ Relative risk (RR) and 95% CI were calculated as 
supportive analysis
▪ The test statistic used was a two-sided x² test with 
a significance level of 0.05
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Statistical Analysis (Continued)
Secondary Outcomes
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Results
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25 Admitting diagnosis 
of thromboembolism
Pre-Implementation Post-Implementation
Total 316 charts 
reviewed assessed 
for inclusion
Most % excluded 




Total: 187 patients 
171   Patient Chart Reviewed145   Patient Chart Reviewed
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Baseline Characteristics
Tony Nguyen Baptist Hospital of Miami








Age – yr 66 (55-75) 69 (59-69)
Male sex – no. (%) 62 (66.0) 62 (66.7)
White Hispanic – no. (%) 76 (80.9) 84 (90.32)
Weight – kg/m2 30.3 ± 5.9 30.0 ± 5.8
Weight Distribution – no. (%)
BMI ≤ 30 49 (52.1) 47 (50.5)
BMI > 30-39.9 38 (40.4) 42 (45.2)
BMI ≥ 40  7 (7.5) 4 (4.3)
More than 3 Comorbidities 16 (17.0) 22 (23.7)
Concomitant antiplatelet – no. (%) 19 (20.2) 45 (48.4)
BMI – Body mass index
*Comorbidities evaluated included: hypertension, diabetes, chronic kidney disease, 
hyperlipidemia, coronary artery disease, cancer, chronic obstructive pulmonary disease
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Table 1.  Baseline Characteristics (Continued)







Hemoglobin, mg/dL 13.3 ± 1.8 13.4 ± 2.1
Platelet, count 212.3 ± 86.3 248.2 ± 103.7
INR* 1.1 (1.1-1.1) 1.1 (1.1-1.2)
Prothrombin time, ms 34.8 ± 20.5 31.1 ± 4.9
D-dimer, mcg/mL
* 3.6 ± 10.3 2.8 ± 4.7
Ferritin, mcg/L 1468.2 ± 3337.4 811.4 ± 654.1
INR – International normalized ratio
*INR, D-dimer expressed as median with lower and upper quartile ranges
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Clinical Outcomes
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Table 2. Sub-group Analysis
Prophylaxis Intermediate Treatment















7 (10.3) 9 (15.0) 0 (0) 4 (15.4) 0 (0) 2 (25)
In-hospital mortality 23 (33.8) 20 (33.3) 2 (28.6) 9 (34.6) 11 (58.9) 2 (25)
Any bleeding 6 (8.8) 7 (11.7) 1 (14.3) 2 (7.7) 3 (15.8) 3 (37.5)
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Primary Outcome – no. (%)
Venous Thromboembolism 7 (7.5) 13 (14.0) 1.88 (0.78 to 4.50)
Pulmonary embolism 1 (1.1) 2 (2.2)
Deep vein thrombosis 6 (6.4) 11 (11.83)
Tony Nguyen Baptist Hospital of Miami
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Figure 1. Relative Risk of Venous Thromboembolism in Pre- vs. Post-Implementation 
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Secondary Outcomes – no.(%)
Bleeding, any 10 (10.6) 12 (12.8)
In-hospital mortality 36 (38.3) 31 (33.0)
Tony Nguyen Baptist Hospital of Miami
Conclusions
Implementation of an anticoagulation dosing 
guideline for the prevention of VTE in critically ill 
patients infected with COVID-19 had no observable 
difference on the incidence of VTE, however 
observed a statistically significant difference in the 
prescribing of intermediate and treatment dose 
orders.
Tony Nguyen Baptist Hospital of Miami
Self-Assessment Questions
T/F: Unless contraindicated, routine 
prophylactic-intensity anticoagulation is 
recommended for all critically ill patients 
infected with COVID-19.
Tony Nguyen Baptist Hospital of Miami
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